{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:06:39Z","timestamp":1793815599325,"version":"4.6.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.neuropharm.2023.109689","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T06:10:14Z","timestamp":1692339014000},"page":"109689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-8728","authenticated-orcid":false,"given":"James J.","family":"Gattuso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2222-9714","authenticated-orcid":false,"given":"Carey","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Renoir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2023.109689_bib1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/da.22501","article-title":"Ketamine's mechanism of action: a path to rapid\u2010acting antidepressants","volume":"33","author":"Abdallah","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2023.109689_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(09)60240-3","article-title":"Obsessive-compulsive disorder","author":"Abramowitz","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2023.109689_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11587860-000000000-00000","article-title":"Pharmacological management of treatment-resistant obsessive-compulsive disorder","volume":"25","author":"Abudy","year":"2011","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2023.109689_bib4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.biopsych.2016.04.023","article-title":"Increased metabotropic glutamate receptor 5 signaling underlies obsessive-compulsive disorder-like behavioral and striatal circuit abnormalities in mice","volume":"80","author":"Ade","year":"2016","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/npp.2015.26","article-title":"Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice","volume":"40","author":"Aida","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib6","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1111\/j.1471-4159.1993.tb07472.x","article-title":"Sex differences in acute swim stress\u2010induced changes in the binding of MK\u2010801 to the NMDA subclass of glutamate receptors in mouse forebrain","volume":"61","author":"Akinci","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2023.109689_bib7","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1038\/npp.2008.41","article-title":"Involvement of pallidotegmental neurons in methamphetamine-and MK-801-induced impairment of prepulse inhibition of the acoustic startle reflex in mice: reversal by GABAB receptor agonist baclofen","volume":"33","author":"Arai","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HRP.0000000000000330","article-title":"Ketamine in the treatment of obsessive-compulsive disorder: a systematic review","volume":"30","author":"Bandeira","year":"2022","journal-title":"Harv. Rev. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib9","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2010","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0014-2999(03)01274-3","article-title":"The mouse light\/dark box test","volume":"463","author":"Bourin","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/schbul\/19.2.233","article-title":"Information processing and attention dysfunctions in schizophrenia","volume":"19","author":"Braff","year":"1993","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2023.109689_bib12","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1152\/ajpregu.00831.2005","article-title":"NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL\/6J mice","volume":"291","author":"Bryant","year":"2006","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib13","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/npp.2015.44","article-title":"Environmental enrichment ameliorates behavioral impairments modeling schizophrenia in mice lacking metabotropic glutamate receptor 5","volume":"40","author":"Burrows","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib14","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1523\/JNEUROSCI.1701-11.2011","article-title":"Sapap3 deletion anomalously activates short-term endocannabinoid-mediated synaptic plasticity","volume":"31","author":"Chen","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-021-26247-2","article-title":"Ketamine increases activity of a fronto-striatal projection that regulates compulsive behavior in SAPAP3 knockout mice","volume":"12","author":"Davis","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109689_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1146\/annurev.ne.16.030193.001231","article-title":"The role of NMDA receptors in information processing","volume":"16","author":"Daw","year":"1993","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","article-title":"Men and mice: relating their ages","volume":"152","author":"Dutta","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib18","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/2041-210X.12584","article-title":"BORIS: a free, versatile open\u2010source event\u2010logging software for video\/audio coding and live observations","volume":"7","author":"Friard","year":"2016","journal-title":"Methods Ecol. Evol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib19","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/sj.mp.4001159","article-title":"Mouse genetic models for prepulse inhibition: an early review","volume":"7","author":"Geyer","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib20","doi-asserted-by":"crossref","unstructured":"Glorie, D., Verhaeghe, J., Miranda, A., de Lombaerde, S., Stroobants, S., Staelens, S., 2021. Quantification of metabotropic glutamate receptor 5 availability with both [11C] ABP688 and [18F] FPEB positron emission tomography in the Sapap3 knockout mouse model for obsessive compulsive-like behavior. Biol. Psychiatr. Cogn. Neurosci. Neuroimaging. 7, 607-615.","DOI":"10.1016\/j.bpsc.2021.11.010"},{"key":"10.1016\/j.neuropharm.2023.109689_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108160","article-title":"Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: a longitudinal [11C] ABP688 PET study","volume":"177","author":"Glorie","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib22","first-page":"257","article-title":"Obsessive-compulsive disorder","volume":"37","author":"Goodman","year":"2014","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.neuropharm.2023.109689_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40360-021-00534-6","article-title":"Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis","volume":"22","author":"Hadi","year":"2021","journal-title":"BMC Pharmacol. Toxicol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48637-9","article-title":"Aberrant habit formation in the Sapap3-knockout mouse model of obsessive-compulsive disorder","volume":"9","author":"Hadjas","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109689_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-020-0747-3","article-title":"Projection-specific deficits in synaptic transmission in adult Sapap3-knockout mice","volume":"45","author":"Hadjas","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib26","series-title":"NMDA Receptors","first-page":"1","article-title":"NMDA receptors in the central nervous system","author":"Hansen","year":"2017"},{"key":"10.1016\/j.neuropharm.2023.109689_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-7-25","article-title":"Behavioral effects of ketamine and toxic interactions with psychostimulants","volume":"7","author":"Hayase","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib28","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder: advances in diagnosis and treatment","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.neuropharm.2023.109689_bib29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.biopsych.2005.01.040","article-title":"Impaired prepulse inhibition of acoustic startle in obsessive-compulsive disorder","volume":"57","author":"Hoenig","year":"2005","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib30","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2007.07.014","article-title":"Pre-but not post-menopausal female CBA\/CaJ mice show less prepulse inhibition than male mice of the same age","volume":"185","author":"Ison","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib31","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrn.2015.8","article-title":"Neurobiology of rodent self-grooming and its value for translational neuroscience","volume":"17","author":"Kalueff","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-020-00621-5","article-title":"Clozapine generates obsessive compulsive disorder-like behavior in mice","volume":"13","author":"Kang","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2023.109689_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms15475","article-title":"Prevalence of sexual dimorphism in mammalian phenotypic traits","volume":"8","author":"Karp","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2023.109689_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/neu.2014.17","article-title":"Effects of single and combined gabapentin use in elevated plus maze and forced swimming tests","volume":"26","author":"Kilic","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jpsychires.2012.11.018","article-title":"Prepulse inhibition in psychiatric disorders\u2013apart from schizophrenia","volume":"47","author":"Kohl","year":"2013","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib36","doi-asserted-by":"crossref","first-page":"825","DOI":"10.12740\/PP\/105130","article-title":"Treatment of obsessive-compulsive disorders (OCD) and obsessive-compulsive-related disorders (OCRD)","volume":"53","author":"Krzyszkowiak","year":"2019","journal-title":"Psychiatr. Pol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00213-002-1099-x","article-title":"Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research","volume":"162","author":"Kumari","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109689_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5498\/wjp.v2.i6.86","article-title":"Obsessive-compulsive disorder: evidence-based treatments and future directions for research","volume":"2","author":"Lack","year":"2012","journal-title":"World J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib39","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1503\/jpn.180032","article-title":"Lateral orbitofrontal dysfunction in the Sapap3 knockout mouse model of obsessive\u2013compulsive disorder","volume":"44","author":"Lei","year":"2019","journal-title":"J. Psychiatr. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.npp.1301191","article-title":"The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice","volume":"32","author":"Lipina","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0924-977X(03)00063-4","article-title":"Gender in obsessive\u2013compulsive disorder: clinical and genetic findings","volume":"14","author":"Lochner","year":"2004","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.neuropharm.2023.109689_bib42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.5607\/en.2019.28.6.697","article-title":"Recapitulation of neuropsychiatric behavioral features in mice using acute low-dose MK-801 administration","volume":"28","author":"Mabunga","year":"2019","journal-title":"Exp Neurobiol"},{"key":"10.1016\/j.neuropharm.2023.109689_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0278-5846(99)00112-8","article-title":"Effects of 3, 4-methylenedioxy-methamphetamine (MDMA) on anxiety in mice tested in the light-dark box","volume":"24","author":"Maldonado","year":"2000","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109689_bib44","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/s41386-018-0307-2","article-title":"Impaired instrumental reversal learning is associated with increased medial prefrontal cortex activity in Sapap3 knockout mouse model of compulsive behavior","volume":"44","author":"Manning","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib45","first-page":"989","article-title":"Distinct patterns of abnormal lateral orbitofrontal cortex activity during compulsive grooming and reversal learning normalize after fluoxetine","volume":"99","author":"Manning","year":"2021","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-88769-5","article-title":"Disruption of prepulse inhibition is associated with compulsive behavior severity and nucleus accumbens dopamine receptor changes in Sapap3 knockout mice","volume":"11","author":"Manning","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2023.109689_bib47","doi-asserted-by":"crossref","first-page":"856","DOI":"10.3390\/brainsci11070856","article-title":"Therapeutic potentials of ketamine and esketamine in obsessive\u2013compulsive disorder (OCD), substance use disorders (sud) and eating disorders (ed): a review of the current literature","volume":"11","author":"Martinotti","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib48","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1271\/bbb.90095","article-title":"Effects of Psilocybe argentipes on marble-burying behavior in mice","volume":"73","author":"Matsushima","year":"2009","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.neuropharm.2023.109689_bib49","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.4088\/JCP.v67n1110","article-title":"Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder","volume":"67","author":"Moreno","year":"2006","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.113093","article-title":"Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice","volume":"401","author":"Odland","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib51","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s00213-017-4666-x","article-title":"Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono-or adjunct therapy","volume":"234","author":"Onaolapo","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2023.109689_bib52","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1460-9568.2011.07628.x","article-title":"Molecular basis of NMDA receptor functional diversity","volume":"33","author":"Paoletti","year":"2011","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41380-019-0431-3","article-title":"Lower excitatory synaptic gene expression in orbitofrontal cortex and striatum in an initial study of subjects with obsessive compulsive disorder","volume":"26","author":"Piantadosi","year":"2021","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0166-4328(02)00124-9","article-title":"Physical and emotional stress have differential effects on preference for saccharine and open field behaviour in rats","volume":"139","author":"Pijlman","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/JCP.0b013e3181727548","article-title":"Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up","volume":"28","author":"Pittenger","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib56","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41386-021-01161-9","article-title":"Optogenetic inhibition of indirect pathway neurons in the dorsomedial striatum reduces excessive grooming in Sapap3-knockout mice","volume":"47","author":"Ram\u00edrez-Armenta","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2019.01.046","article-title":"Obsessive-compulsive disorder: puzzles and prospects","author":"Robbins","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2023.109689_bib58","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bbr.2017.06.009","article-title":"Environmental enrichment reduces innate anxiety with no effect on depression-like behaviour in mice lacking the serotonin transporter","volume":"332","author":"Rogers","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib60","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41398-023-02456-9","article-title":"Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder","volume":"13","author":"Singh","year":"2023","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2023.109689_bib61","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","article-title":"Mechanism of NMDA receptor channel block by MK-801 and memantine","volume":"556","author":"Song","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109689_bib62","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/da.22474","article-title":"Prepulse inhibition deficits only in females with obsessive\u2013compulsive disorder","volume":"33","author":"Steinman","year":"2016","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2023.109689_bib63","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0b013e3181c856de","article-title":"A single-blinded case-control study of memantine in severe obsessive-compulsive disorder","volume":"30","author":"Stewart","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2012.09.002","article-title":"Update: studies of prepulse inhibition of startle, with particular relevance to the pathophysiology or treatment of Tourette Syndrome","author":"Swerdlow","year":"2013","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2023.109689_bib65","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.biopsych.2006.06.035","article-title":"Neural circuits containing pallidotegmental GABAergic neurons are involved in the prepulse inhibition of the startle reflex in mice","volume":"62","author":"Takahashi","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib66","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.conb.2011.04.010","article-title":"Neurobiology of obsessive\u2013compulsive disorder: insights into neural circuitry dysfunction through mouse genetics","volume":"21","author":"Ting","year":"2011","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2023.109689_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2019.08.004","article-title":"Higher prevalence of irritable bowel syndrome and greater gastrointestinal symptoms in obsessive-compulsive disorder","volume":"118","author":"Turna","year":"2019","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib68","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbr.2013.08.017","article-title":"Ketamine increases striatal dopamine release and hyperlocomotion in adult rats after postnatal functional blockade of the prefrontal cortex","volume":"256","author":"Usun","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2023.109689_bib69","doi-asserted-by":"crossref","first-page":"g2183","DOI":"10.1136\/bmj.g2183","article-title":"Obsessive-compulsive disorder","volume":"348","author":"Veale","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2023.109689_bib70","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.biopsych.2013.01.008","article-title":"Circuit-selective striatal synaptic dysfunction in the Sapap3 knockout mouse model of obsessive-compulsive disorder","volume":"75","author":"Wan","year":"2014","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2023.109689_bib71","doi-asserted-by":"crossref","first-page":"16685","DOI":"10.1523\/JNEUROSCI.2533-11.2011","article-title":"Sapap3 deletion causes mGluR5-dependent silencing of AMPAR synapses","volume":"31","author":"Wan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib72","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature06104","article-title":"Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice","volume":"448","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2023.109689_bib73","article-title":"Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behaviours","volume":"106223","author":"Wilson","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2023.109689_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.107998","article-title":"Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction","volume":"168","author":"Wilson","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib75","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0023","article-title":"Monoamine abnormalities in the SAPAP3 knockout model of obsessive-compulsive disorder-related behaviour","volume":"373","author":"Wood","year":"2018","journal-title":"Phil. Trans. Biol. Sci."},{"key":"10.1016\/j.neuropharm.2023.109689_bib76","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/sj.npp.1300480","article-title":"The effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice","volume":"29","author":"Yee","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2023.109689_bib77","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41419-022-04876-9","article-title":"SAPAP3 regulates epileptic seizures involving GluN2A in post-synaptic densities","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390823002794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:26:13Z","timestamp":1758439573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390823002794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":77,"alternative-id":["S0028390823002794"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109689","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2023.109689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109689"}}